IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Wacker Adds to Biologics Capacity in Germany

November 7, 2007 |

Alex Scott

Wacker Chemie (Munich, Germany) says it will invest €15 million ($22 million) to expand its biopharmaceuticals manufacturing operations at Jena, Germany. The investment program will include two projects; a new manufacturing facility to go online at the end of 2009; and a new building for process development and quality control scheduled for completion in late 2008. “The new facilities will enable us to greatly accelerate our growth in the attractive biologics market,” says Gerhard Schmid, president of Wacker Fine Chemicals, the group’s...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa